🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

A Symptom Management Application for Children at the Early Stage of Cancer Survivorship and Their Caregivers

RecruitingNAAges 9 Years - 16 YearsAllChinese University of Hong Kong
NCT05748210 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this randomized controlled trial is to examine the efficacy of the mHealth app in improving symptoms experienced by children in the early stage of cancer survivorship, including physical function, anxiety, depressive symptoms, fatigue, peer relationships, and pain interference, and at improving the quality of life (QoL) of the children's primary caregivers The main question it aims to answer is whether survivors who receive the symptom management mHealth app intervention will report improved symptoms, i.e., improved physical function; lower levels of anxiety, depressive symptoms, and fatigue; better peer relationships; and lower pain interference 3 months after starting the intervention. Additionally, we hypothesized that the primary caregivers (either the mother or father) would report an improved QoL 3 months after starting the intervention. Participants in the interventi

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: Chinese paediatric cancer survivors will be included if they * are aged 9 to 16 years, * are able to read Chinese and communicate in Chinese, * have completed active cancer treatment (within the previous 2 years), as early symptom management support is crucial to reduce the symptom burden in survivors and their caregivers throughout their survivorship, and * have a smartphone or tablet and are willing to install the mHealth app. The primary caregiver of the paediatric cancer survivors (either the mother or father) * are able to read Chinese and communicate in Chinese, and * have a smartphone or tablet and are willing to install the mHealth app with their children surviving cancer. Exclusion Criteria: Chinese paediatric cancer survivors will be excluded if they * have cognitive impairments or psychiatric illnesses * are currently participating in other symptom management studies, or * have evidence of secondary malignancy or recurrence The primary caregivers of the paediatric cancer survivors (either the mother or father) will be excluded if they have cognitive impairments or psychiatric illnesses.
💊

What it tests

  • Symptom management mobile health application with personalised support
  • Wait-list Symptom management mobile health application with personalised support
📍

Where

2 sites
The Chinese University of Hong Kong
Hong Kong, Hong Kong
The Chinese University of Hong Kong
Hong Kong, Hong Kong
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy